HCP Access

My Account
Logout

Patients Website

My Account
Logout

en-sa
- en-sa
- en-uae
- en-kw
- en-qa
- en-bh
- en-om

CVRM
Oncology
Hematology
Respiratory
Biologics
Vaccine & Immunology
Rare Disease
AZ Spotlight 2024
Care Corner
Gastrointestinal
Resources-backup-24-04-2019
Live Events
Recorded Videos
COVID-19 updates
Iframe Test Page
Test-page
test-page-1
Recorded Videos
Online Courses
VITAL
TEST-COVID
Intellin Dashboard
Pharmacist
Vaccine & Immunology-Old
Vaccine and Immunologybkup
test
Pharmacist
Pharmacist-test
Impact Academy-BACKUP
World Patient Safety Day
AZ-World Disease day
AZ-Week/Value
Patient Centricity
Educational Hub
Testing
PDF Reviewer
resource-test

More Hide
en-sa
- en-sa
- en-uae
- en-kw
- en-qa
- en-bh
- en-om

Know your Patient’s risk
for Kidney Disease?

Find out if your patients might have silent chronic kidney disease now. Please note that this is not intended to replace the advice of a healthcare professional. Always consult doctor.

Take Survey

What is CKD?

Chronic Kidney Disease also known as CKD is a condition where the kidneys get damaged and can no longer filter blood the way that they should. This means toxins start building up in the body. If not detected in time, CKD can be fatal.

Configure Image Component

Screening
for CKD

It is recommended that screening in adults with CKD or at risk for CKD be done by testing for albuminuria. Albumin-to-creatinine ratio (ACR) is the first method of preference to detect elevated protein. The recommended method to evaluate albuminuria is to measure urinary ACR in a spot urine sample.

iFrameDescription

Loading......

REQUEST A VISIT FROM AN AstraZeneca REPRESENTATIVE

Modal Window Component Section Begins

Configure Modal Window Component - #popup-1733845101112

Modal Window Component Section Ends

Thank you for visiting the AstraZeneca Medicines website

This link will take you to a website not owned by AstraZeneca. AstraZeneca provides this link as a service to our site visitors. AstraZeneca are not responsible for the content or privacy / legal policies of any third party websites.

Do you wish to continue?

Cancel Continue

Thank you for visiting the AstraZeneca Medicines website

Do you wish to continue?

Cancel Continue

Validating...

Disclaimer pop-up

Are you a licensed healthcare professional practicing in the UAE, KSA, Qatar, Kuwait, Oman, or Bahrain

AstraZeneca EduGate

This website is intended for doctors, nurses, and pharmacists in GCC countries. Others please visit www.astrazeneca.com.

Additional Info

Legal Notice and Terms of Use
Privacy Notice
Cookie Policy

Contact AstraZeneca

Contact Us
Report Adverse Event

Adverse events should be reported. Reporting forms and information can be found at aereporting.astrazeneca.com. Adverse events should also be reported to AstraZeneca Saudi on +966112249235 / email at ksa.ae@astrazeneca.com

في حالة وجود أي أعراض جانبیة للأدویة الرجاء التواصل مع الهیئة العامة للغذاء والدواء عن طریق الرقم الموحد 19999

Approval Code: SA-2772 / Y1-1123

For Medical information Enquires
Website: https://contactazmedical.astrazeneca.com
E-mail: medinfo-ksa@astrazeneca.com

Al-Nakhla Tower - Floor 13th Ath Thumamah, Road - Al
Sahafa District. 7198 Unit No. 20 Riyadh 13315 – 3642.
Tel: +966 (011) 22 492 00
Fax: +966 (011) 22 492 91

Configure Footer Reference Component

Reference